Androgen Suppression: The Good, The Bad and The Ugly

Prostate cancer is a significant health problem for men in the USA and worldwide. Nearly thirty thousand American men die each year of advanced prostate cancer. The androgen receptor, a member of the family of nuclear receptors, is a key modulator in development of prostate cancer and of prostate cancer progression. Therefore the androgen receptor is a well-established target for therapeutic intervention in prostate cancer.

• Publication year

  2012

• Venue

  Journal of Andrology

• Publication date

  2012-02-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2167-0250.1000E106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MDV3100 for the treatment of prostate cancer

  2012cited by this paper
• Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

  2011cited by this paper
• Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor.

  2010cited by this paper
• In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors

  2009cited by this paper
• HE3235 inhibits growth of castration-resistant prostate cancer.

  2009cited by this paper
• Genomic strategy for targeting therapy in castration-resistant prostate cancer.

  2009cited by this paper
• Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.

  2008cited by this paper
• Persistent intraprostatic androgen concentrations after medical castration in healthy men.

  2006cited by this paper
• PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor

  2006cited by this paper
• Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.

  2006cited by this paper
• The androgen receptor and signal‐transduction pathways in hormone‐refractory prostate cancer. Part 2: androgen‐receptor cofactors and bypass pathways

  2005cited by this paper
• Signal transduction in prostate cancer progression.

  2005cited by this paper
• The androgen receptor and signal‐transduction pathways in hormone‐refractory prostate cancer. Part 1: modifications to the androgen receptor

  2005cited by this paper
• Androgen Receptor Cross-talk with Cell Signalling Pathways

  2004cited by this paper
• The Androgen Axis in Recurrent Prostate Cancer

  2004cited by this paper
• Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.

  2000cited by this paper

• Androgen receptor modulators: a marriage of chemistry and biology.

  2013cites this paper
• The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton

  2013cites this paper